Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04967118
Other study ID # 296/2018
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 2, 2023
Est. completion date December 31, 2024

Study information

Verified date November 2023
Source University of Oulu
Contact Anna-Kaija Palomaa
Phone +358400892159
Email annakaija.palomaa@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this randomized controlled study with crossover design is to examine the effectiveness of mother-driven interventions, skin-to-skin contact (SSC) and recorded mother's heartbeats as sound and vibration (MHB), compared to oral glucose in relieving neonatal acute pain related to heel lance as a painful procedure. The effectiveness of interventions will be assessed using validated pain scales (PIPP-R and NIAPAS), changes in sensory cortex activation (near-infrared spectroscopy, NIRS) and changes in physiological indicators (oxygen saturation, heart rate, respiratory rate). The secondary objectives will include evaluating the effectiveness of interventions in relation to infant recovery and evaluating the use of NIRS monitoring in relation to neonatal pain assessment scales.


Recruitment information / eligibility

Status Recruiting
Enrollment 36
Est. completion date December 31, 2024
Est. primary completion date May 31, 2024
Accepts healthy volunteers No
Gender All
Age group 32 Weeks to 42 Weeks
Eligibility Inclusion Criteria: - Gestational Age (GA) at birth 32+0 - 42+0 - Admitted to NICU - Parents are able to read, write and speak Finnish Exclusion Criteria: - With a postnatal age of 14 days or more - Apgar points were 6 or less at 5 minutes of age - Has been found grade III or IV cerebral haemorrhage - Major congenital anomalies - Has intubated or receiving a nCPAP - Has received analgesics or sedatives for less than 24 hours prior to the study

Study Design


Intervention

Behavioral:
Skin-to-skin contact
Diaper clad baby will be placed ventral position on bare chest of mother 30 minute prior to the heel lance
Mother's heartbeats as sound and vibration
The mother's heartbeat will be recorded and the heartbeat sounds will be saved to the platform. The platform will be placed under the infant's mattress and the heartbeat will be started 30 minute prior to the heel lance.
Drug:
30% oral glucose
The infant will be given 30% oral glucose solution 2 minutes before the injection

Locations

Country Name City State
Finland Oulu University Hospita Oulu

Sponsors (1)

Lead Sponsor Collaborator
University of Oulu

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in scores of Premature Infant Pain profile-Revised (PIPP-R) scale Pain intensity will be assessed using pain assessment tool, the Premature Infant Pain Profile Revised (PIPP-R). PIPP-R is an internationally widely used multidimensional pain assessment scale consisting of three behavioral indicators, two physiological indicators, and two contextual indicators. Baseline 1, measured pre-intervention
Primary Change in scores of Premature Infant Pain profile-Revised (PIPP-R) scale Pain intensity will be assessed using pain assessment tool, the Premature Infant Pain Profile Revised (PIPP-R). PIPP-R is an internationally widely used multidimensional pain assessment scale consisting of three behavioral indicators, two physiological indicators, and two contextual indicators. Baseline 2, measured pre-procedure
Primary Change in scores of Premature Infant Pain profile-Revised (PIPP-R) scale Pain intensity will be assessed using pain assessment tool, the Premature Infant Pain Profile Revised (PIPP-R). PIPP-R is an internationally widely used multidimensional pain assessment scale consisting of three behavioral indicators, two physiological indicators, and two contextual indicators. Measured during painful procedure
Primary Change in scores of Premature Infant Pain profile-Revised (PIPP-R) scale Pain intensity will be assessed using pain assessment tool, the Premature Infant Pain Profile Revised (PIPP-R). PIPP-R is an internationally widely used multidimensional pain assessment scale consisting of three behavioral indicators, two physiological indicators, and two contextual indicators. Measured immediately after painful procedure
Primary Change in scores of Neonatal Infant Acute Pain Assessment Scale (NIAPAS) Pain intensity will be assessed using pain assessment tool, the Neonatal Infant Acute Pain Assessment Scale (NIAPAS). NIAPAS is multidimensional pain assessment scale used in Finland. It consist of five behavioral indicators, three physiological indicators, and one contextual indicator. Baseline 1, measured pre-intervention
Primary Change in scores of Neonatal Infant Acute Pain Assessment Scale (NIAPAS) Pain intensity will be assessed using pain assessment tool, the Neonatal Infant Acute Pain Assessment Scale (NIAPAS). NIAPAS is multidimensional pain assessment scale used in Finland. It consist of five behavioral indicators, three physiological indicators, and one contextual indicator. Baseline 2, measured pre-procedure
Primary Change in scores of Neonatal Infant Acute Pain Assessment Scale (NIAPAS) Pain intensity will be assessed using pain assessment tool, the Neonatal Infant Acute Pain Assessment Scale (NIAPAS). NIAPAS is multidimensional pain assessment scale used in Finland. It consist of five behavioral indicators, three physiological indicators, and one contextual indicator. Measured during painful procedure
Primary Change in scores of Neonatal Infant Acute Pain Assessment Scale (NIAPAS) Pain intensity will be assessed using pain assessment tool, the Neonatal Infant Acute Pain Assessment Scale (NIAPAS). NIAPAS is multidimensional pain assessment scale used in Finland. It consist of five behavioral indicators, three physiological indicators, and one contextual indicator. Measured immediately after painful procedure
Primary Change in the activation in the somatosensory cortical areas following the noxious stimulation (baseline) In this study pain will be assessed measuring changes cortical hemodynamics by near-infrared spectroscopy (NIRS). A 2-channel NIRS will be used. The emitted probe provides near-infrared light through on optical fiber will be is placed slightly posterior to Cz position with reference to the international EEG 10-20 system. The receive probes will be fastened over somatosensory and occipital area. In the area of the somatosensory cortex, receive probes will be placed 2 to 4 cm from the emitted probe so that they are placed slightly behind C3 or C4 point. The occipital region receive probe will be attached 2 to 4 cm from the emitted probe. Baseline 1, measured pre-intervention
Primary Change in the activation in the somatosensory cortical areas following the noxious stimulation In this study pain will be assessed measuring changes cortical hemodynamics by near-infrared spectroscopy (NIRS). A 2-channel NIRS will be used. The emitted probe provides near-infrared light through on optical fiber will be is placed slightly posterior to Cz position with reference to the international EEG 10-20 system. The receive probes will be fastened over somatosensory and occipital area. In the area of the somatosensory cortex, receive probes will be placed 2 to 4 cm from the emitted probe so that they are placed slightly behind C3 or C4 point. The occipital region receive probe will be attached 2 to 4 cm from the emitted probe. Baseline 2, measured pre-procedure
Primary Change of the activation in the somatosensory cortical areas following the noxious stimulation In this study pain will be assessed measuring changes cortical hemodynamics by near-infrared spectroscopy (NIRS). A 2-channel NIRS will be used. The emitted probe provides near-infrared light through on optical fiber will be is placed slightly posterior to Cz position with reference to the international EEG 10-20 system. The receive probes will be fastened over somatosensory and occipital area. In the area of the somatosensory cortex, receive probes will be placed 2 to 4 cm from the emitted probe so that they are placed slightly behind C3 or C4 point. The occipital region receive probe will be attached 2 to 4 cm from the emitted probe. Measured during painful procedure
Primary Change of the activation in the somatosensory cortical areas following the noxious stimulation In this study pain will be assessed measuring changes cortical hemodynamics by near-infrared spectroscopy (NIRS). A 2-channel NIRS will be used. The emitted probe provides near-infrared light through on optical fiber will be is placed slightly posterior to Cz position with reference to the international EEG 10-20 system. The receive probes will be fastened over somatosensory and occipital area. In the area of the somatosensory cortex, receive probes will be placed 2 to 4 cm from the emitted probe so that they are placed slightly behind C3 or C4 point. The occipital region receive probe will be attached 2 to 4 cm from the emitted probe. Measured immediately after painful procedure
Primary Change in heart rate (HR) Neonates' physiological reactions to procedural pain during heel lance will be monitored continuously and measured by recording changes in heart rate using bedside patient monitor. Baseline 1, measured pre-intervention
Primary Change in heart rate (HR) Neonates' physiological reactions to procedural pain during heel lance will be monitored continuously and measured by recording changes in heart rate using bedside patient monitor. Baseline 2, measured pre-procedure
Primary Change in heart rate (HR) Neonates' physiological reactions to procedural pain during heel lance will be monitored continuously and measured by recording changes in heart rate using bedside patient monitor. Measured during painful procedure
Primary Change in heart rate (HR) Neonates' physiological reactions to procedural pain during heel lance will be monitored continuously and measured by recording changes in heart rate using bedside patient monitor. Measured immediately after procedure
Primary Change in oxygen saturation Neonates' physiological reactions to procedural pain during heel lance will be monitored continuously and measured by recording changes in oxygen saturation using bedside patient monitor. Baseline 1, measured pre-intervention
Primary Change in oxygen saturation Neonates' physiological reactions to procedural pain during heel lance will be monitored continuously and measured by recording changes in oxygen saturation using bedside patient monitor. Baseline 2, measured pre-procedure
Primary Change in oxygen saturation Neonates' physiological reactions to procedural pain during heel lance will be monitored continuously and measured by recording changes in oxygen saturation using bedside patient monitor. Measured during painful procedure
Primary Change in oxygen saturation Neonates' physiological reactions to procedural pain during heel lance will be monitored continuously and measured by recording changes in oxygen saturation using bedside patient monitor. Measured immediately after painful procedure
Primary Change in respiratory rate Neonates' physiological reactions to procedural pain during heel lance will be monitored continuously and measured by recording changes in respiratory rate using bedside patient monitor. Baseline 1, measured pre-intervention
Primary Change in respiratory rate Neonates' physiological reactions to procedural pain during heel lance will be monitored continuously and measured by recording changes in respiratory rate using bedside patient monitor. Baseline 2, measured pre-procedure
Primary Change in respiratory rate Neonates' physiological reactions to procedural pain during heel lance will be monitored continuously and measured by recording changes in respiratory rate using bedside patient monitor. Measured during procedure
Primary Change in respiratory rate Neonates' physiological reactions to procedural pain during heel lance will be monitored continuously and measured by recording changes in respiratory rate using bedside patient monitor. Measured immediately after procedure
Secondary Recovery measured by change in scores of the Premature Infant Pain profile-Revised (PIPP-R) Time to recovery from painful stimulus will be considered the amount of time in minutes that pass until the neonates' PIPP-R scores returns to baseline values. 3 minutes after painful procedure
Secondary Recovery measured by change in scores of the Premature Infant Pain profile-Revised (PIPP-R) Time to recovery from painful stimulus will be considered the amount of time in minutes that pass until the neonates' PIPP-R scores returns to baseline values. 5 minutes after painful procedure
Secondary Recovery measured by change in scores of the Premature Infant Pain profile-Revised (PIPP-R) Time to recovery from painful stimulus will be considered the amount of time in minutes that pass until the neonates' PIPP-R scores returns to baseline values. 10 minutes after painful procedure
Secondary Recovery measured by change in scores of the Neonatal Infant Acute Pain Assessment Scale (NIAPAS) Time to recovery from painful stimulus will be considered the amount of time in minutes that pass until the neonates' NIAPAS scores returns to baseline values. 3 minutes after painful procedure
Secondary Recovery measured by change in scores of the Neonatal Infant Acute Pain Assessment Scale (NIAPAS) Time to recovery from painful stimulus will be considered the amount of time in minutes that pass until the neonates' NIAPAS scores returns to baseline values. 5 minutes after painful procedure
Secondary Recovery measured by change in scores of the Neonatal Infant Acute Pain Assessment Scale (NIAPAS) Time to recovery from painful stimulus will be considered the amount of time in minutes that pass until the neonates' NIAPAS scores returns to baseline values. 10 minutes after painful procedure
Secondary Recovery as measured by changes in somatosensory cortex activation Time to recovery from painful stimulus will be considered the amount of time in minutes that pass until the activation in the somatosensory cortical area measured by NIRS returns to baseline values. 3 minutes after painful procedure
Secondary Recovery as measured by changes in somatosensory cortex activation Time to recovery from painful stimulus will be considered the amount of time in minutes that pass until the activation in the somatosensory cortical area measured by NIRS returns to baseline values. 5 minutes after painful procedure
Secondary Recovery as measured by changes in somatosensory cortex activation Time to recovery from painful stimulus will be considered the amount of time in minutes that pass until the activation in the somatosensory cortical area measured by NIRS returns to baseline values 10 minutes after painful procedure
Secondary Recovery as measured by changes in heart rate (HR) The physiological responses of neonates to recovery from the pain of the procedure are continuously monitored and measured by recording changes in respiratory rate using a patient monitor. 3 minutes after painful procedure
Secondary Recovery as measured by changes in heart rate (HR) The physiological responses of neonates to recovery from the pain of the procedure are continuously monitored and measured by recording changes in respiratory rate using a patient monitor. 5 minutes after painful procedure
Secondary Recovery as measured by changes in heart rate (HR) The physiological responses of neonates to recovery from the pain of the procedure are continuously monitored and measured by recording changes in respiratory rate using a patient monitor. 10 minutes after painful procedure
Secondary Recovery as measured by changes in oxygen saturation The physiological responses of neonates to recovery from the pain of the procedure are continuously monitored and measured by recording changes in oxygen saturation using a patient monitor. 3 minutes after painful procedure
Secondary Recovery as measured by changes in oxygen saturation The physiological responses of neonates to recovery from the pain of the procedure are continuously monitored and measured by recording changes in oxygen saturation using a patient monitor. 5 minutes after painful procedure
Secondary Recovery as measured by changes in oxygen saturation The physiological responses of neonates to recovery from the pain of the procedure are continuously monitored and measured by recording changes in oxygen saturation using a patient monitor. 10 minutes after painful procedure
Secondary Recovery as measured by changes in respiratory rate The physiological responses of neonates to recovery from the pain of the procedure are continuously monitored and measured by recording changes in respiratory rate using a patient monitor. 3 minutes after painful procedure
Secondary Recovery as measured by changes in respiratory rate The physiological responses of neonates to recovery from the pain of the procedure are continuously monitored and measured by recording changes in respiratory rate using a patient monitor. 5 minutes after painful procedure
Secondary Recovery as measured by changes in respiratory rate The physiological responses of neonates to recovery from the pain of the procedure are continuously monitored and measured by recording changes in respiratory rate using a patient monitor. 10 minutes after painful procedure
See also
  Status Clinical Trial Phase
Completed NCT05396820 - Adaptation of the Motor System to Experimental Pain N/A
Completed NCT04356963 - Adjunct VR Pain Management in Acute Brain Injury N/A
Recruiting NCT06350084 - Effect of Mother's Touch and Nurse's Therapeutic Touch on Pain Level and Crying Time During Heel Blood Collection N/A
Completed NCT04080037 - Assessing Opioid Care Practices Using CPV Patient Simulation Modules N/A
Recruiting NCT05458037 - RCT of Pain Perception With Fast and Slow Tenaculum Application N/A
Completed NCT04571515 - Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain Phase 2
Completed NCT06005480 - Understanding Rebound Pain After Regional Anesthesia Resolution in Healthy Volunteers Phase 1
Active, not recruiting NCT04850079 - EHR Precision Drug Treatment in Neonates
Completed NCT03272139 - Interscalene Block Versus Superior Trunk Block Phase 4
Completed NCT03271151 - Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty Phase 4
Recruiting NCT05383820 - Effect of Paracetamol and Ketorolac on RANK-L Levels in Patients Starting Orthodontic Treatment Phase 4
Completed NCT04851353 - Multiple Sensory Interventions On Infants' Pain and Physiological Distress During Neonatal Screening Procedures N/A
Completed NCT03280017 - Ketamine With Multilevel Paravertebral Block for Post Video-assisted Thoracic Surgery Pain Phase 4
Completed NCT04280796 - Changes in Affective Pain Processing in Human Volunteers N/A
Not yet recruiting NCT04491630 - COping With PAin Through Hypnosis, Mindfulness and Spirituality N/A
Not yet recruiting NCT04523623 - Pain Control Differences Between Oxycodone and Ibuprofen in Children With Isolated Forearm Injuries N/A
Not yet recruiting NCT04062513 - Olfactive Stimulation Interventions With Mothers' Milk on Preterm Pain Response N/A
Withdrawn NCT03137017 - A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults Phase 1
Withdrawn NCT03137030 - A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy Adults Phase 1
Completed NCT04659395 - How to Develop a Training Program for Nurses in Ultrasound Guided Femoral Nerve Block N/A